Stanford University Biodesign Program, Stanford University, 318 Campus Drive, Stanford, CA 94305-5428, USA.
Ann Biomed Eng. 2013 Sep;41(9):1803-10. doi: 10.1007/s10439-013-0761-2. Epub 2013 Feb 13.
The Stanford Biodesign Program began in 2001 with a mission of helping to train leaders in biomedical technology innovation. A key feature of the program is a full-time postgraduate fellowship where multidisciplinary teams undergo a process of sourcing clinical needs, inventing solutions and planning for implementation of a business strategy. The program places a priority on needs identification, a formal process of selecting, researching and characterizing needs before beginning the process of inventing. Fellows and students from the program have gone on to careers that emphasize technology innovation across industry and academia. Biodesign trainees have started 26 companies within the program that have raised over $200 million and led to the creation of over 500 new jobs. More importantly, although most of these technologies are still at a very early stage, several projects have received regulatory approval and so far more than 150,000 patients have been treated by technologies invented by our trainees. This paper reviews the initial outcomes of the program and discusses lessons learned and future directions in terms of training priorities.
斯坦福大学生物设计项目始于 2001 年，其使命是帮助培训生物医学技术创新方面的领导者。该项目的一个重要特点是设立了一个全职研究生奖学金，多学科团队在其中经历了一个从寻找临床需求、发明解决方案到规划商业战略实施的过程。该项目优先考虑需求识别，即在发明过程开始之前，通过正式的程序选择、研究和描述需求。该项目的研究员和学生继续从事强调跨行业和学术界的技术创新的职业。生物设计培训生已经在该项目中创办了 26 家公司，这些公司已筹集了超过 2 亿美元的资金，并创造了超过 500 个新的工作岗位。更重要的是，尽管这些技术大多仍处于早期阶段，但已有几个项目获得了监管部门的批准，到目前为止，已有超过 15 万名患者接受了我们培训生发明的技术治疗。本文回顾了该项目的初步成果，并讨论了培训重点方面的经验教训和未来方向。
